For our visitors who seek the latest industry news and updates to keep abreast with the goings-on
of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and
diverse feed of news items.
Hunan Hansen Pharmaceutical Co Ltd Expects net profit for 2016 to fluctuate by -20 percent to 10 percent, or to be 78.5 million yuan to 107.9 million yuan.
Says the net profit of 2015 was 98.1 million yuan.
Comments that increased expenses and rising initial investment in subsidiary are the…
Renhe Pharmacy Co., Ltd. Says its wholly owned units to set up 75-pct-owned technology JV, 70-pct-owned pharmaceutical JV and 70-pct-owned biotechnology JV in Jiangxi respectively.
Says the three JVs to be capitalized at 5 million yuan, 5 million yuan and 2 million yuan respectively.
Source : reuters.com
A slowdown in sales of AbbVie Inc's (ABBV.N) Humira arthritis treatment sent the drugmaker's shares 6 percent lower on Friday, highlighting the company's heavy reliance on the $15 billion-a-year medicine.
Humira sales increased 11.3 percent in the third quarter, compared with growth of 14.9 percent and 17.4 percent, respectively, in…
Mumbai-based Glenmark Pharmaceuticals on Thursday posted Rs 223.6 crore in net profit, up by 3.5% over last year for the second quarter ended September 30 due to strong growth in markets like the US and the performance of its active pharmaceutical ingredient (API) business.
Glenmark had posted a consolidated net…
Indian drug major Sun Pharma has launched in the US generic versions of Japanese pharmaceutical firm Daiichi Sankyo's Benicar, Benicar HCT, Azor and Tribenzor, which are used to treat high blood pressure.
These brands together recorded US sales of approximately $2.5 billion between August 31, 2015 and August 31, 2016,…
Sanofi has struck a collaboration deal with a leading Brazilian research institute to speed development of a Zika vaccine, consolidating the French drugmaker's position in the race to defeat the mosquito-borne virus.
The deal with the Fiocruz public health center follows a tie-up in July between Sanofi and a U.S.…
Allergan plc., a leading global pharmaceutical company and Rhythm Holding Company, LLC, which owns Motus Therapeutics, Inc. a biopharmaceutical company developing peptide therapeutics for the treatment of gastrointestinal (GI) disorders, announced today the top line results of a Phase 2b clinical trial assessing the efficacy and safety of relamorelin (RM-131),…
Innate Pharma Sa Preliminary data from dose-escalation part of an ongoing Phase I trial in elderly and heavily pretreated patients including a majority of patients with sezary syndrome.
IPH4102 shows good safety profile.
Encouraging signs of clinical activity, with complete responses seen in skin and blood.
Source : reuters.com
Dr Reddy's Laboratories today said it has entered into a collaboration with Gland Pharma to market and distribute a diverse portfolio of eight injectable Abbreviated New Drug Applications (ANDAs) in the US market.
Gland Pharma is a city-based developer and manufacturer of sterile dosage forms.
The portfolio is a mix…